C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/337 (2006.01) A61K 31/4465 (2006.01) A61K 31/496 (2006.01) A61K 31/551 (2006.01) A61K 39/395 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2424689
The present invention relates to orally active salts of compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
L'invention concerne des sels de composés oralement actifs, qui inhibent, régulent ou modulent la transduction de signal de la tyrosine kinase. L'invention concerne également des compositions contenant ces composés, ainsi que des procédés d'utilisation de ces sels pour traiter des maladies et des états associés à la tyrosine kinase, tels que l'angiogenèse, le cancer, la croissance tumorale, l'athérosclérose, la dégénérescence maculaire liée à l'âge, la rétinopathie diabétique, des maladies inflammatoires et des pathologies similaires chez les mammifères.
Fraley Mark E.
Karki Shyam B.
Kim Yuntae
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Orally active salts with tyrosine kinase activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orally active salts with tyrosine kinase activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally active salts with tyrosine kinase activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1766932